Detalhe da pesquisa
1.
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circ Res
; 122(3): 479-488, 2018 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29208679
2.
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Circ Res
; 122(12): 1703-1715, 2018 06 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29703749
3.
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
Am Heart J
; 201: 54-62, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29910056
4.
Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) study.
Am Heart J
; 183: 24-34, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27979038
5.
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circ Res
; 116(1): 99-107, 2015 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-25406300
6.
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
Am Heart J
; 179: 142-50, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27595689
7.
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
Circ Res
; 114(10): 1564-8, 2014 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-24812350
8.
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
Circ Res
; 115(10): 867-74, 2014 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-25136078
9.
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells.
Am Heart J
; 168(5): 667-73, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25440794
10.
The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases.
Circ Res
; 118(12): 1867-71, 2016 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27283530
11.
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA
; 307(16): 1717-26, 2012 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-22447880
12.
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA
; 308(22): 2380-9, 2012 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-23129008
13.
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use.
Cardiovasc Res
; 118(11): 2428-2436, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34387303
14.
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA
; 306(19): 2110-9, 2011 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-22084195
15.
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Eur J Heart Fail
; 23(4): 661-674, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33811444
16.
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
JACC CardioOncol
; 2(4): 581-595, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33403362
17.
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.
Stem Cells Transl Med
; 5(2): 186-91, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26683870
18.
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
Cell Transplant
; 25(9): 1675-1687, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26590374